Targeting STAT3 in hepatocellular carcinoma: sorafenib again…

J Hepatol. 2011 Nov;55(5):957-9. doi: 10.1016/j.jhep.2011.06.005. Epub 2011 Jun 28.
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Animals
  • Benzenesulfonates / pharmacology*
  • Carcinoma, Hepatocellular / drug therapy*
  • Humans
  • Liver Neoplasms / drug therapy*
  • Niacinamide / analogs & derivatives
  • Phenylurea Compounds
  • Protein Kinase Inhibitors / pharmacology*
  • Pyridines / pharmacology*
  • STAT3 Transcription Factor / drug effects*
  • Sorafenib

Substances

  • Benzenesulfonates
  • Phenylurea Compounds
  • Protein Kinase Inhibitors
  • Pyridines
  • STAT3 Transcription Factor
  • Niacinamide
  • Sorafenib